Inra spinout Nextbiotix has attracted capital from the institute itself as well as Biocodex and other institutional investors.

EMS subsidiary Brace Pharma Capital returned to help HPV therapy developer Antiva Biosciences increase its overall funding to $57m.

CNA Financial, NN Group and an unnamed insurance provider have supplied $75m for MTech's InsureTech fund, which has targeted a $150m close.

T. Rowe Price Associates led a series D round that valued GV-backed point-of-sale system developer Toast at $1.4bn.

The autonomous driving technology developer has added $102m to a series A round backed by Comcast and Legend Holdings that now totals $214m.

The SIG-backed digital media company is reportedly considering an initial public offering in its home country.

JD.com's financial services spinoff has raised at least $1.95bn at a reported $18bn valuation from backers including Bank of China and CICC.

Osage University Partners has returned to back a series C1 round for Antiva, which is developing treatments for HPV and is based on research at UC San Diego.

Cryptocurrency exchange platform Binance has invested in a first round for Oasis Labs, based on research by Dawn Song at UC Berkeley.